Livio Trentin

14PUBLICATIONS
61CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Jul 30, 2025
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring.

Francesco Angotzi, Alessandro Cellini, Nicolò Danesin

|Jun 12, 2025
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso

|Apr 16, 2025
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort.

Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino

|Jan 06, 2025
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype.

Andrea Serafin, Valeria Ruocco, Alessandro Cellini

|Jul 01, 2024
How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia.

Nayla Mouawad, Edoardo Ruggeri, Guido Capasso

Pageof 3

Frequent Collaborators

7 joint publications

Andrea Visentin

6 joint publications

Luca Laurenti

6 joint publications

Livio Trentin

4 joint publications

Massimo Gentile